You searched for "age"
Normative data using a virtual reality game-based visual field test
The authors present a prospective cross-sectional study involving healthy children to assess the use of a virtual reality game-based perimetry assessment. A single eye centre recruited through paediatric optometry and ophthalmology clinics over a 12-month period. Children aged <18 years...Urban Changes and Rural Struggles for Ophthalmology in China
1 December 2013
| Anne-Line Crochet, Christopher Liu (Prof)
China is by far the most populated country in the world, with over 1.3 billion inhabitants. It is also the country with the highest number of blind and visually impaired people. As a developing country, half of China’s population lives...
New College of Optometrists President and Council members announced
The College of Optometrists welcomed a new President and seven new Council members at its AGM, held during the College’s clinical conference, Optometry Tomorrow 2024 - now incorporating BCLA Focus - in Telford on 29 April.
Comparison of visual field indices between normal adults and children
The authors present a prospective observational study which aimed to compare visual field indices with retinal nerve fibre layer (RNFL) thickness using optical coherence tomography (OCT) in normal adults and children. Children aged 6–18 years were recruited from a single...Eyes Right: Older People and Driving
Eyesight deteriorates gradually with age. This updated publication has been developed to assist nurses working with older people who present with eyesight issues. It includes details on eye health, visual impairment and ageing, highlights nurses’ responsibilities and signposts for further...
Nerve head in healthy humans using OCT-angiography
1 December 2017
| Chrysostomos D Dimitriou
|
EYE - Glaucoma
Optical coherence tomography angiography (OCT-A) is a recent, dyeless, and noninvasive imaging technique for evaluating depth-resolved vascular status by capturing the dynamic motion of the erythrocytes. It provides the flow map of major vessels and capillary plexuses separately in different...
Effect of anti-VEGF treatment on PED morphology
1 June 2015
| Jaya Myneni
|
EYE - Vitreo-Retinal
This retrospective study of 30 eyes assessed the effect of anti-VEGF on morphology of pigment epithelial detachments (PED) secondary to age-related macular degeneration (AMD). Thirty eyes of 28 patients with PED were compared to 30 eyes of 30 patients with...
Aqueous humour cytokine levels in PCV and nAMD
1 April 2015
| Bheemanagouda Patil
|
EYE - Vitreo-Retinal
This study looks into the possible roles of various cytokines or growth factors in the pathogenesis of exudative age-related macular degeneration (AMD) by comparing aqueous levels of 14 cytokines between eyes with polypoidal choroidal vasculopathy (PCV) and those with neovascular...
Neurofibromatosis type 1 features
The aim in this study was to identify the incidence and de nova mutation rate of Neurofibramatosis type 1 (NF1) and describe the ocular and non-ocular findings in a population-based cohort of patients diagnosed over a 30-year period. The study...
Assessment of slow and fast vergence in stroke survivors
5 April 2022
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors present the findings of a prospective cohort study. Three hundred and five stroke survivors were recruited consecutively. The following exclusion criteria were applied; aphasia, cognitive impairment, visual inattention, ocular motor nerve palsy and neuromuscular disease. Fifty age-matched controls...
BT outcomes for accommodative esotropia
The purpose of this study was to study the effect of Botulinum Toxin (BT) in refractive and non-refractive accommodative esotropia unresponsive to glasses and poor compliance with glasses. This was a retrospective study of 114 patients who had BT for...
Progression of macular atrophy on long-term anti-VEGF therapy for AMD
3 October 2022
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
Anti-VEGF therapy, Long term, Macular atrophy, neovascular age-related macular degeneration
This retrospective study evaluated the progression of macular atrophy in 53 eyes of 53 patients receiving AntiVEGF Therapy for age-related macular degeneration (nAMD), for at least six years. None of the patients had any macular atrophy (MA) at presentation. MA...
